MedPath

TRIMERIS

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:2

Trial Phases

2 Phases

Phase 1:2
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 1
2 (66.7%)
Phase 2
1 (33.3%)

Study of Enfuvirtide in HIV-Positive Subjects

Phase 1
Completed
Conditions
HIV Infections
AIDS
First Posted Date
2004-07-13
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Target Recruit Count
26
Registration Number
NCT00086710
Locations
🇺🇸

SFBC, Miami, Florida, United States

A Rollover Study to Provide Chronic T-1249 to Patients Who Completed Study T1249-102

Phase 1
Conditions
HIV Infections
First Posted Date
2002-10-30
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Registration Number
NCT00048217
Locations
🇺🇸

Trimeris, Durham, North Carolina, United States

A Study of T-20 in HIV-Positive Adults

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2005-06-24
Lead Sponsor
Trimeris
Target Recruit Count
78
Registration Number
NCT00002228
Locations
🇺🇸

Univ of Alabama at Birmingham / 1917 AIDS O/P Cln, Birmingham, Alabama, United States

🇺🇸

UCLA School of Medicine / Ctr for Research and Education, Los Angeles, California, United States

🇺🇸

San Francisco Gen Hosp, San Francisco, California, United States

and more 8 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.